Massachusetts Financial Services
BTAI icon

Massachusetts Financial Services’s BioXcel Therapeutics BTAI Stock Holding History

Massachusetts Financial Services’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,970
Closed -$4.15M – 843
2023
Q2 		$4.15M Buy
38,970
+16,215
+71% +$5.4M ﹤0.01% 657
2023
Q1 		$6.79M Sell
22,755
-5,705
-20% -$2.44M ﹤0.01% 631
2022
Q4 		$9.78M Buy
28,460
+93
+0.3% +$22.5K ﹤0.01% 612
2022
Q3 		$5.37M Buy
28,367
+1,928
+7% +$448K ﹤0.01% 648
2022
Q2 		$5.58M Sell
26,439
-197
-0.7% -$41.4K ﹤0.01% 647
2022
Q1 		$8.91M Buy
26,636
+731
+3% +$212K ﹤0.01% 645
2021
Q4 		$8.43M Sell
25,905
-189
-0.7% -$81.1K ﹤0.01% 671
2021
Q3 		$12.7M Buy
26,094
+8,109
+45% +$3.57M ﹤0.01% 654
2021
Q2 		$8.36M Sell
17,985
-53
-0.3% -$28.9K ﹤0.01% 680
2021
Q1 		$12.5M Sell
18,038
-435
-2% -$350K ﹤0.01% 647
2020
Q4 		$13.7M Buy
18,473
+341
+2% +$266K ﹤0.01% 622
2020
Q3 		$12.6M Sell
18,132
-446
-2% -$335K ﹤0.01% 611
2020
Q2 		$15.8M Buy
18,578
+1,428
+8% +$931K 0.01% 573
2020
Q1 		$6.13M Buy
+17,150
New +$6.16M ﹤0.01% 626

Other funds holding BTAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services's BTAI Position: Q3 2023 in Review

Massachusetts Financial Services sold out of BioXcel Therapeutics (BTAI) in Q3 2023, closing a stake of 38,970 shares — an estimated $4.15M sold.

Massachusetts Financial Services first reported a position in BTAI in Q1 2020 and held it in 14 quarters. The position peaked at $15.8M in Q2 2020. 85 funds tracked by Wall St. Rank hold BTAI as of Q3 2023.

  • Massachusetts Financial Services reported no remaining BioXcel Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 38,970 BioXcel Therapeutics shares in Q3 2023, an estimated $4.15M.
  • Massachusetts Financial Services first reported a position in BioXcel Therapeutics in Q1 2020 and held it in 14 quarters.
  • Massachusetts Financial Services's BioXcel Therapeutics position peaked at $15.8M in Q2 2020.
  • 85 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q3 2023.

Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.